BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

March 31, 2020

View Archived Issues
3-31-Medtronic-Evolut-PRO.png

Excellent outcomes for Medtronic Evolut TAVR in low-risk bicuspid AVS patients

Results of a study presented at the American College of Cardiology's Annual Scientific Session on March 29 demonstrated “excellent” outcomes following transcatheter aortic valve replacement (TAVR) using the Medtronic plc Evolut in low surgical risk patients with bicuspid aortic valve stenosis. Read More
eye-tech.png

Citing COVID-19, Second Sight to wind down operations

It has been predicted that the COVID-19 pandemic would cause business disruption. Now, it has claimed a casualty with Second Sight Medical Products Inc., of Sylmar, Calif., which has been forced to wind down operations, citing the pandemic and the impact it will have on the company’s ability to secure financing. Second Sight, which makes the Argus II retinal prosthesis system, said that effective March 31, 84 of its 108 employees will be laid off. Read More
Cancer-and-Cancer-immunotherapy.png

Grail liquid biopsy test broadly detects cancers, particularly aggressive ones, in large study

Systematic detection of cancer at earlier stages at a population level could remodel how the medical profession approaches cancer treatment, establishing the potential to reduce cancer mortality by almost one-quarter. That’s according to an analysis based on the latest data from Grail Inc.'s Circulating Cell-free Genome Atlas (CCGA) study. Read More
3-31-Siemens-RAPIDPoint-500e.png

FDA gives nod to Siemens Healthineers’ Rapidpoint 500e blood gas analyzer

Erlangen, Germany-based Siemens Healthineers AG has secured U.S. FDA clearance for its Rapidpoint 500e blood gas analyzer. Available in CE mark countries since August 2019, the device is used to monitor respiratory distress in critically ill patients, such as those in acute care due to COVID-19. Read More
EU-coronavirus

European IVD med-techs upping efforts to launch rapid COVID-19 screening tests

PARIS – Europe has turned into the epicenter of the coronavirus pandemic, seeing more than 50% of the cases observed worldwide. In fact, whereas the COVID-19 pandemic has begun declining in China where it originated, there are 400,000 cases of coronavirus worldwide, including more than 200,000 infected by SARS-CoV-2 in the 55 sovereign states in continental Europe, where they are mourning more than 18,000 deaths. Read More

Appointments and advancements for March 31, 2020

New hires and promotions in the med-tech industry, including: Bellaseno, Iridex, S4 Medical. Read More

Financings for March 31, 2020

Med-tech firms raising money in public or private financings, including: Artio Medical, Icad, Orthospin, Pavmed. Read More

In the clinic for March 31, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Edwards, Grail, Pixium Vision. Read More

Other news to note for March 31, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, Airon, Aroa Biosurgery, Battelle, Behold.ai Technologies, Carterra, Cubic, Dräger, Echosens, Evqlv, Ford, GE Healthcare, General Motors, Houston Methodist Hospital, Immunoprecise Antibodies, JR Automation, Luminati, Luminex, Metaphy Health, Navidea Biopharmaceuticals, Neumodx, Northwell Health, NTI Nanotechnology, Ozo Life, Phillips-Medsize, Procept, Sectra, Sense Biodetection, Stagezero Life Sciences, Viral Protection Labs, Virgin Orbit, Wellbeing Software, Worldcare Clinical. Read More

Regulatory actions for March 31, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cytosorbents, Enlightenvue, Qiagen, Siemens Healthineers. Read More

Regulatory front for March 31, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Becton Dickinson, Biotechnology Innovation Organization, Cme America, Ortho-Clinical Diagnostics. Read More

BioWorld MedTech’s Oncology Extra for March 31, 2020

Keeping you up to date on recent developments in oncology, including: How lung tumors seed to brain; UVA looks to genes to improve cancer outcomes; Study shows promise of immunotherapy against solid tumors. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 11, 2025.
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing